These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 26587016)

  • 1. Therapeutic Actions of the Thiazolidinediones in Alzheimer's Disease.
    Pérez MJ; Quintanilla RA
    PPAR Res; 2015; 2015():957248. PubMed ID: 26587016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review.
    Dinda B; Dinda M; Kulsi G; Chakraborty A; Dinda S
    Eur J Med Chem; 2019 May; 169():185-199. PubMed ID: 30877973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurotrophic factor small-molecule mimetics mediated neuroregeneration and synaptic repair: emerging therapeutic modality for Alzheimer's disease.
    Kazim SF; Iqbal K
    Mol Neurodegener; 2016 Jul; 11(1):50. PubMed ID: 27400746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disease modifying effect of chronic oral treatment with a neurotrophic peptidergic compound in a triple transgenic mouse model of Alzheimer's disease.
    Kazim SF; Blanchard J; Dai CL; Tung YC; LaFerla FM; Iqbal IG; Iqbal K
    Neurobiol Dis; 2014 Nov; 71():110-30. PubMed ID: 25046994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Signaling Mechanisms of Selective PPAR
    Govindarajulu M; Pinky PD; Bloemer J; Ghanei N; Suppiramaniam V; Amin R
    PPAR Res; 2018; 2018():2010675. PubMed ID: 30420872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pathological changes induced by amyloid-β in Alzheimer's disease].
    Takata K; Kitamura Y; Taniguchi T
    Yakugaku Zasshi; 2011 Jan; 131(1):3-11. PubMed ID: 21212607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic Strategies Targeting Amyloid-β in Alzheimer's Disease.
    Pinheiro L; Faustino C
    Curr Alzheimer Res; 2019; 16(5):418-452. PubMed ID: 30907320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Alzheimer disease: cellular and molecular aspects].
    Octave JN
    Bull Mem Acad R Med Belg; 2005; 160(10-12):445-9; discussion 450-1. PubMed ID: 16768248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Therapy of Alzheimer disease].
    Kovács T
    Neuropsychopharmacol Hung; 2009 Mar; 11(1):27-33. PubMed ID: 19731816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of Wnt signaling by lithium and rosiglitazone reduced spatial memory impairment and neurodegeneration in brains of an APPswe/PSEN1DeltaE9 mouse model of Alzheimer's disease.
    Toledo EM; Inestrosa NC
    Mol Psychiatry; 2010 Mar; 15(3):272-85, 228. PubMed ID: 19621015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular and Cellular Basis of Neurodegeneration in Alzheimer's Disease.
    Jeong S
    Mol Cells; 2017 Sep; 40(9):613-620. PubMed ID: 28927263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroprotective Effect of Fisetin Against Amyloid-Beta-Induced Cognitive/Synaptic Dysfunction, Neuroinflammation, and Neurodegeneration in Adult Mice.
    Ahmad A; Ali T; Park HY; Badshah H; Rehman SU; Kim MO
    Mol Neurobiol; 2017 Apr; 54(3):2269-2285. PubMed ID: 26944285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plaque formation and the intraneuronal accumulation of β-amyloid in Alzheimer's disease.
    Takahashi RH; Nagao T; Gouras GK
    Pathol Int; 2017 Apr; 67(4):185-193. PubMed ID: 28261941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term pioglitazone treatment improves learning and attenuates pathological markers in a mouse model of Alzheimer's disease.
    Searcy JL; Phelps JT; Pancani T; Kadish I; Popovic J; Anderson KL; Beckett TL; Murphy MP; Chen KC; Blalock EM; Landfield PW; Porter NM; Thibault O
    J Alzheimers Dis; 2012; 30(4):943-61. PubMed ID: 22495349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autophagy and Alzheimer's Disease: From Molecular Mechanisms to Therapeutic Implications.
    Uddin MS; Stachowiak A; Mamun AA; Tzvetkov NT; Takeda S; Atanasov AG; Bergantin LB; Abdel-Daim MM; Stankiewicz AM
    Front Aging Neurosci; 2018; 10():04. PubMed ID: 29441009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alzheimer's disease and amyloid: culprit or coincidence?
    Skaper SD
    Int Rev Neurobiol; 2012; 102():277-316. PubMed ID: 22748834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous infusion of monocytes isolated from 2-week-old mice enhances clearance of Beta-amyloid plaques in an Alzheimer mouse model.
    Hohsfield LA; Humpel C
    PLoS One; 2015; 10(4):e0121930. PubMed ID: 25830951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA in Alzheimer's disease revisited: implications for major neuropathological mechanisms.
    Dehghani R; Rahmani F; Rezaei N
    Rev Neurosci; 2018 Feb; 29(2):161-182. PubMed ID: 28941357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammatory mechanisms in Alzheimer's disease: inhibition of beta-amyloid-stimulated proinflammatory responses and neurotoxicity by PPARgamma agonists.
    Combs CK; Johnson DE; Karlo JC; Cannady SB; Landreth GE
    J Neurosci; 2000 Jan; 20(2):558-67. PubMed ID: 10632585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.